INSIGHTFUL-FFR Clinical Trial

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-85
SponsorCoreAalst BV

About this trial

Recently, a new device for measuring physiological lesion severity, the pressure microcatheter, was introduced. The pressure microcatheter provides similar information to the conventional measurement technique but differs as it is easily advanced on a customary coronary wire and simplifies pullback maneuvers. The pressure microcatheter has been shown to provide comparable FFR results to pressure wires.

Insightful-FFR is an investigator-driven, multicenter, randomized, open-label and prospective trial of patients with stable coronary artery disease or stabilised non-ST elevation acute coronary syndrome (ACS) with epicardial stenosis considered for PCI aiming at comparing clinical outcomes between pressure microcatheter and pressure wire-guided strategies. The study hypothesis states that the use of a Pressure Microcatheter for clinical decision making would be non-inferior to pressure wire-based strategy

After determining the presence of a coronary artery disease/ stabilized acute coronary syndrome, patients will be randomized to use a pressure microcatheter (investigational device) or a pressure wire (comparator) to guide and optimize percutaneous coronary intervention (PCI). Patients will be followed up in hospital at 12 months and yearly until five years.

Eligibility criteria

Qualifiers

The subject must be at least 18 years of age and younger than 85 years old.

Eligible for elective PCI.

Stable angina or ACS (non-culprit vessels only and outside of primary intervention during acute STEMI)

Subject willing to participate and able to understand, read and sign the Informed Consent.

Disqualifiers

STEMI as clinical presentation.

Chronic total occlusion as a target vessel.

Significant contraindication to adenosine administration (e.g. heart block, severe asthma)

Uncontrolled or recurrent ventricular tachycardia.

Trial design

Treatments tested in this trial

  • Pressure Microcatheter guided strategy - PIOS MC
  • Pressure Wire guided strategy - PIOS - PW
  • Pressure Microcatheter guided strategy - Standard of care
  • Pressure Wire guided strategy - Standard of care

Treatment groups

2,500 Participants
are divided into 4 treatment groups

Sponsors and collaborators

CoreAalst BV

Lead sponsor

Insight Lifetech Co., Ltd.

Collaborator